Cagrilintide Description
Cagrilintide is a long‑acting amylin analogue that helps reduce appetite, slow gastric emptying, and improve glycemic control. It is studied for obesity and type 2 diabetes, often in combination with GLP‑1 receptor agonists.
Benefits of Cagrilintide
- Reduces appetite and cravings
- Supports significant weight loss in trials
- Improves glycemic control in type 2 diabetes
- Potential synergy with GLP‑1 therapies
